Subscribe
A worldwide window to Cambridge business, innovation and technology
Hiverge clinches $5m to build ‘algorithm factory’

Hiverge clinches $5m to build ‘algorithm factory’

Cambridge startup Hiverge, launched by former Google DeepMind research leaders, has clinched $5 million seed funding to accelerate a pathfinding ‘algorithm factory’.
Arm and CuspAI grab glory at Business Weekly Awards as Raspberry Pi wins double

Arm and CuspAI grab glory at Business Weekly Awards as Raspberry Pi wins double

Cambridge-based startup CuspAI, which has just unveiled $100 million funding from global investors, was named Business of the Year at the 35th Anniversary Business Weekly Awards at Queens' College, Cambridge last night.
Deal with Lilly blossoms as Alchemab raises a further $32m and extends Series A to $114m

Deal with Lilly blossoms as Alchemab raises a further $32m and extends Series A to $114m

Cambridge biopharma company Alchemab Therapeutics has raised an additional $32 million to help advance its portfolio and has progressed a mega-deal with Eli Lilly and Company. The raise takes its Series A round past the $114m mark.
CuspAI confirms $100m+ raise from global heavyweights as Hyundai joins throng

CuspAI confirms $100m+ raise from global heavyweights as Hyundai joins throng

Cambridge-based AI for materials science company CuspAI has confirmed a $100 million+ Series A round – led by global heavyweights NEA and Temasek, with participation from NVIDIA’s NVentures, Samsung Ventures and new backer Hyundai Motor Group.
NRG Therapeutics clinches oversubscribed $67m Series B

NRG Therapeutics clinches oversubscribed $67m Series B

NRG Therapeutics, a neuroscience company targeting a novel mechanism to address mitochondrial dysfunction, has closed an oversubscribed $67 million (£50m) Series B financing round.
Academia
Sharewatch
Manufacturing
Nxera and Cancer Research UK advance trials of advanced solid tumour treatment
17 Sep 2025 - 12:00
Cambridge scientists say 'Virtual child' and other AI initiatives can create new drugs
10 Sep 2025 - 12:00
Artificial cartilage to blitz conditions such as arthritis could be worth billions
09 Sep 2025 - 12:00

Business awards

Entries now being accepted

Business directory

Browse our listings of Cambridge companies

The killer 50

The 50 hottest disruptive technology companies

News

Start smart: How AI gives tech startups a strategic edge from day one

Start smart: How AI gives tech startups a strategic edge from day one

In a world where speed, focus, and adaptability are everything, a new generation of tech startups is showing how to turn artificial intelligence (AI) into a structural advantage – not just an efficiency tool, writes Paul Hughes – Managing Director, Life Sciences & Technology at BDO.
President Trump flies into Stansted as Air Force One returns to the airport for State visit

President Trump flies into Stansted as Air Force One returns to the airport for State visit

London Stansted Airport has again welcomed Air Force One as President Donald Trump and First Lady Melania Trump arrived at the start of their second state visit to the UK.
Nxera and Cancer Research UK advance trials of advanced solid tumour treatment

Nxera and Cancer Research UK advance trials of advanced solid tumour treatment

Cambridge and Japan company Nxera Pharma and Cancer Research UK say the first patient has been dosed in a Phase 2a clinical trial evaluating Nxera’s investigational immunotherapy drug HTL0039732 (also known as NXE0039732) for advanced solid tumours.
Hiverge clinches $5m to build ‘algorithm factory’

Hiverge clinches $5m to build ‘algorithm factory’

Cambridge startup Hiverge, launched by former Google DeepMind research leaders, has clinched $5 million seed funding to accelerate a pathfinding ‘algorithm factory’.
More news

Tech trail

Hiverge clinches $5m to build ‘algorithm factory’

Hiverge clinches $5m to build ‘algorithm factory’

Cambridge startup Hiverge, launched by former Google DeepMind research leaders, has clinched $5 million seed funding to accelerate a pathfinding ‘algorithm factory’.
Enhanced Genomics takes Series A round to $19m

Enhanced Genomics takes Series A round to $19m

Enhanced Genomics has completed a funding round that extends its total Series A raise to $19 million. Backers were BGF, Parkwalk and Meltwind.
Double diamonds: Big hitters spearhead new era for Cambridge Innovation Capital

Double diamonds: Big hitters spearhead new era for Cambridge Innovation Capital

Venture Capital doyen Cambridge Innovation Capital, which invests in major DeepTech and life sciences companies, has made two senior appointments.
Deal with Lilly blossoms as Alchemab raises a further $32m and extends Series A to $114m

Deal with Lilly blossoms as Alchemab raises a further $32m and extends Series A to $114m

Cambridge biopharma company Alchemab Therapeutics has raised an additional $32 million to help advance its portfolio and has progressed a mega-deal with Eli Lilly and Company. The raise takes its Series A round past the $114m mark.
More Tech trail

Trade floor

Realising strategic tech acquisitions in a volatile market

Realising strategic tech acquisitions in a volatile market

The 2025 M & A landscape has been defined by a mix of cautious optimism and strategic recalibration, writes Jonathan Greenwood, corporate partner at leading UK law firm Mills & Reeve.
HVSS Group plugs into Mills & Reeve for acquisition of electrical contractor

HVSS Group plugs into Mills & Reeve for acquisition of electrical contractor

Law firm Mills & Reeve has advised independent connection provider HVSS Group on its maiden acquisition of a Norwich specialist electrical contractor. Northamptonshire-based HVSS Group has bought AM Electrics (Renewables) in a move that will further enhance its capabilities in delivering integrated infrastructure solutions.
South Korea's Telechips puts Arm tech behind the wheel

South Korea's Telechips puts Arm tech behind the wheel

Cambridge superchip architect Arm reveals that Telechips, a global fabless semiconductor manufacturer specialising in automotive, has chosen a leading-edge suite of Arm® IP for its nextgen automotive system-on-chip (SoC), the Dolphin5.
Schneider Electric joins the Kew and plants seeds of progress for Royal Botanic Gardens

Schneider Electric joins the Kew and plants seeds of progress for Royal Botanic Gardens

Schneider Electric has unveiled a strategic partnership with Royal Botanic Gardens, Kew (RBG) to help it become climate positive by 2030.
SeqOne in France buying Sanger spin-out Congenica to create world leader in AI-powered genomic medicine

SeqOne in France buying Sanger spin-out Congenica to create world leader in AI-powered genomic medicine

Cambridge-based Congenica is being acquired for an undisclosed sum by French company SeqOne but the new entity will retain a base at the Wellcome Sanger Institute from where it was spun out.
More Trade floor